Ligase Targeting Drug Development Summit
Evvnt Promotion / evvnt
07.05.2024 - 09.05.2024 The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Conference themes
The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and utilizing novel E3 ligases. This leaves therapeutic opportunities untapped due to obstacles in ligase screening, structural characterization, and assaying therapeutic efficacy.
The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and utilizing novel E3 ligases. This leaves therapeutic opportunities untapped due to obstacles in ligase screening, structural characterization, and assaying therapeutic efficacy.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2174653-3?pid=4832
Speakers: Andreas Kraemer Principal Investigator Goethe University Frankfurt am Main and Structural Genomics Consortium, and more
URL:
Brochure: https://go.evvnt.com/2174653-3?pid=4832
Speakers: Andreas Kraemer Principal Investigator Goethe University Frankfurt am Main and Structural Genomics Consortium, and more
Enquiries and Registration:
https://go.evvnt.com/2174653-2?pid=4832
Ms. Isabella Hunter
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
